tiprankstipranks
Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity
PremiumMarket NewsAmphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity
3M ago
Amphastar initiated with an Overweight at JPMorgan
PremiumThe Fly
Amphastar initiated with an Overweight at JPMorgan
5M ago
AMPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AMPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Amphastar Director Prins sells $263K in company shares
PremiumThe FlyAmphastar Director Prins sells $263K in company shares
8M ago
AMPH Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AMPH Earnings this Week: How Will it Perform?
9M ago
Amphastar files to sell $300M of convertible senior notes due 2029
PremiumThe Fly
Amphastar files to sell $300M of convertible senior notes due 2029
10M ago
Amphastar management to meet with Piper Sandler
PremiumThe FlyAmphastar management to meet with Piper Sandler
1y ago
Amphastar price target raised to $55 from $43 at Piper Sandler
PremiumThe Fly
Amphastar price target raised to $55 from $43 at Piper Sandler
1y ago
AMPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AMPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100